Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18951096 | Lip Balm Containing Caffeine, Nicotine or Testosterone | November 2024 | March 2025 | Allow | 4 | 1 | 0 | No | No |
| 18842405 | ORAL CARE PRODUCT | August 2024 | February 2025 | Allow | 5 | 0 | 0 | No | No |
| 18781282 | LIP BALM CONTAINING CAFFEINE, NICOTINE OR TESTOSTERONE | July 2024 | August 2024 | Allow | 1 | 0 | 0 | No | No |
| 18781300 | LIP BALM CONTAINING CAFFEINE, NICOTINE OR TESTOSTERONE | July 2024 | August 2024 | Allow | 1 | 0 | 0 | No | No |
| 18614050 | Core Shell Silica Particles and Use for Malodor Reduction | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18602863 | ORAL HYGIENE COMPOSITIONS AND METHODS OF USE | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18586163 | ORAL HYGIENE COMPOSITIONS AND METHODS OF USE | February 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18404339 | ORAL CARE ARTICLE COMPRISING A HYDROPHOBIC DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENT | January 2024 | December 2024 | Allow | 11 | 1 | 0 | No | No |
| 18525147 | WATER SOLUBLE COMPOSITION AND PRODUCTION METHOD THEREOF | November 2023 | January 2024 | Allow | 2 | 0 | 0 | No | No |
| 18495126 | ORAL CARE ARTICLE COMPRISING A HYDROPHOBIC DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING AN ACTIVE AGENT | October 2023 | August 2024 | Allow | 10 | 1 | 0 | No | No |
| 18495174 | ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENT | October 2023 | August 2024 | Allow | 10 | 1 | 0 | No | No |
| 18495090 | ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENT | October 2023 | August 2024 | Allow | 10 | 1 | 0 | No | No |
| 18217568 | WOUND CLEANSING METHOD | July 2023 | June 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 18214964 | COMPOSITIONS AND METHODS FOR DENTAL MINERALIZATION | June 2023 | June 2024 | Allow | 12 | 1 | 0 | No | No |
| 18133529 | WHITENING TOOTHPASTE CAPABLE OF EFFECTIVELY REMOVING DENTAL PLAQUE AND TARTAR | April 2023 | July 2023 | Allow | 3 | 0 | 0 | No | No |
| 18029864 | TOPICAL COMPOSITION FOR NANOBUBBLE COSMETIC | March 2023 | August 2024 | Allow | 16 | 2 | 1 | No | No |
| 18191219 | OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER | March 2023 | January 2024 | Abandon | 10 | 1 | 0 | No | No |
| 18169367 | Core Shell Silica Particles and Use for Malodor Reduction | February 2023 | November 2023 | Allow | 9 | 1 | 0 | No | No |
| 18161529 | Dentifrice composition comprising non-crustacean derived chitosan | January 2023 | February 2025 | Abandon | 25 | 2 | 0 | No | Yes |
| 18159019 | DENTAL MATERIAL COMPOSITIONS FOR CLEANSING AND REMOVAL OF ANIONIC CONTAMINANTS FROM SUBSTRATES & THEIR METHODS OF USE | January 2023 | June 2025 | Allow | 29 | 0 | 0 | No | No |
| 18101047 | Nasal Hygiene Method and Formulation | January 2023 | March 2025 | Abandon | 26 | 3 | 0 | Yes | No |
| 18098033 | METHOD FOR PROVIDING A BEVERAGE ADDITIVE | January 2023 | April 2025 | Allow | 27 | 0 | 0 | No | No |
| 18084879 | Toothpaste Composition | December 2022 | May 2025 | Abandon | 28 | 4 | 0 | Yes | No |
| 18082737 | COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING | December 2022 | March 2024 | Allow | 15 | 2 | 0 | No | No |
| 18066730 | SOLUBLE FIBER LOZENGE | December 2022 | June 2024 | Allow | 18 | 3 | 0 | No | No |
| 18046312 | MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXAMETHASONE | October 2022 | December 2024 | Allow | 27 | 3 | 0 | No | Yes |
| 18046416 | BUPIVACAINE MULTIVESICULAR LIPOSOME FORMULATIONS AND USES THEREOF | October 2022 | December 2024 | Allow | 27 | 3 | 0 | No | Yes |
| 17962748 | Thermally Gelling Drug Formulations | October 2022 | August 2023 | Abandon | 10 | 2 | 1 | No | No |
| 17915453 | PROCESS FOR PRODUCTION OF VITAMIN A | September 2022 | May 2025 | Allow | 31 | 0 | 0 | No | No |
| 17888242 | COMPOSITIONS, PRODUCTS, SYSTEM, AND METHOD FOR PERMING HAIR | August 2022 | January 2024 | Allow | 17 | 1 | 1 | No | No |
| 17887237 | Oral Care Compositions | August 2022 | August 2023 | Abandon | 12 | 2 | 0 | No | No |
| 17869261 | Method for Producing Pet Dental Treat | July 2022 | May 2024 | Allow | 22 | 0 | 0 | No | No |
| 17811035 | ORAL CARE COMPOSITIONS | July 2022 | December 2023 | Allow | 17 | 2 | 0 | No | No |
| 17853862 | Zinc - Amino Acid - Lauryl Sulfate Complex with Antimicrobial Activity | June 2022 | October 2023 | Allow | 16 | 1 | 1 | No | No |
| 17853788 | Oral Care Compositions | June 2022 | June 2023 | Allow | 11 | 1 | 0 | No | No |
| 17847852 | NANO-EMULSION COMPOSITION FOR TOOTH WHITENING AND METHOD FOR PRODUCING THE SAME | June 2022 | September 2024 | Allow | 27 | 4 | 0 | No | No |
| 17807399 | ANTISEPTIC AND/OR ANTI-INFLAMMATORY GEL FOR TREATMENT OF ORAL CAVITY DISEASES COMPRISING POLYVINYL ALCOHOL AND POLYACIDS | June 2022 | August 2024 | Abandon | 26 | 3 | 0 | No | No |
| 17785203 | ASSEMBLY AND METHOD FOR THE PREPARATION OF A WOUND DRESSING | June 2022 | May 2025 | Allow | 36 | 0 | 1 | No | No |
| 17757161 | A MATERIAL FOR THE MANUFACTURING OF OPHTHALMIC IMPLANTS BY PHOTO-POLYMERIZATION METHOD | June 2022 | February 2025 | Allow | 32 | 0 | 0 | No | No |
| 17832556 | COMPOSITIONS AND METHODS FOR DENTAL MINERALIZATION | June 2022 | March 2023 | Allow | 10 | 1 | 0 | No | No |
| 17831150 | Orally Adhering Lozenges Containing Soluble Dietary Fiber | June 2022 | October 2024 | Allow | 29 | 4 | 0 | No | Yes |
| 17828179 | Oral Care Composition Comprising Rottlerin | May 2022 | May 2024 | Abandon | 23 | 2 | 0 | No | Yes |
| 17746817 | ORAL HYGIENE COMPOSITIONS AND METHODS OF USE | May 2022 | January 2024 | Allow | 20 | 2 | 1 | No | No |
| 17661153 | LIPOSOME COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF AND USE THEREOF IN THERAPY | April 2022 | June 2025 | Allow | 37 | 4 | 0 | Yes | No |
| 17717391 | Process For Making An Oral Care Article Of Manufacture | April 2022 | December 2023 | Allow | 21 | 2 | 0 | No | No |
| 17656307 | Oral Care Compositions | March 2022 | November 2023 | Abandon | 19 | 1 | 1 | No | No |
| 17694044 | Oral Care Compositions and Methods of Using the Compositions | March 2022 | June 2025 | Abandon | 39 | 2 | 0 | No | Yes |
| 17642565 | SYSTEM FOR CORNEAL CROSS-LINKING AND CORRECTING VISION BY USING LED CONTACT LENS AND EYE DYE | March 2022 | May 2025 | Allow | 38 | 0 | 0 | No | No |
| 17652948 | Oral Care Whitening Compositions | March 2022 | February 2023 | Allow | 12 | 1 | 0 | No | No |
| 17652496 | Antiperspirant that Reduces/Eliminates Yellowing on Clothing | February 2022 | October 2024 | Abandon | 31 | 4 | 1 | Yes | No |
| 17675285 | Peroxymonosulfate Whitening Strips | February 2022 | September 2024 | Allow | 31 | 4 | 0 | No | No |
| 17668840 | Dental Medicament Applicator | February 2022 | May 2022 | Allow | 3 | 0 | 0 | No | No |
| 17568709 | DITHIONITE SHELF-STABLE SWEETENERS | January 2022 | February 2024 | Abandon | 25 | 2 | 0 | No | No |
| 17620089 | PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL | December 2021 | June 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17618664 | WATER-IN-OIL EMULSION COMPOSITION | December 2021 | June 2024 | Allow | 30 | 0 | 0 | No | No |
| 17542370 | MANUFACTURE OF FREEZE-DRIED COSMETIC | December 2021 | September 2023 | Abandon | 22 | 2 | 0 | No | No |
| 17539273 | ELECTROSPUN DEXTRAN FIBERS AND DEVICES FORMED THEREFROM | December 2021 | August 2024 | Allow | 33 | 2 | 1 | No | No |
| 17538201 | STABLE COMPOSITIONS OF UNCOMPLEXED IODINE AND METHODS OF USE | November 2021 | January 2023 | Allow | 14 | 1 | 0 | No | No |
| 17529319 | Making An Oral Care Article Of Manufacture | November 2021 | April 2023 | Abandon | 17 | 1 | 0 | No | No |
| 17611862 | PHARMACEUTICAL COMPOSITION FOR JOINT DISEASE TREATMENT AND METHOD FOR PRODUCING SAME | November 2021 | May 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17610356 | IMMUNE-STIMULATING COMPOSITIONS FOR AQUACULTURE SPECIES | November 2021 | April 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17519931 | Oral Care Whitening Compositions | November 2021 | January 2022 | Allow | 3 | 0 | 0 | No | No |
| 17519068 | MODIFIER SYSTEM FOR COMPOSITIONS CONTAINING LAYERED DOUBLE HYDROXIDE | November 2021 | April 2023 | Allow | 17 | 1 | 0 | No | No |
| 17512153 | OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER | October 2021 | March 2023 | Abandon | 17 | 1 | 0 | No | No |
| 17606637 | DUCTILE COATING FOR AN IMPLANT COMPONENT | October 2021 | June 2024 | Allow | 31 | 0 | 0 | No | No |
| 16770787 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST A BASAL INSULIN WHICH PI IS COMPRISED BETWEEN 5.8 AND 8.5 AND A COPOLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | October 2021 | January 2025 | Abandon | 56 | 1 | 0 | No | No |
| 17599725 | LONG-LASTING COSMETIC COMPOSITION | September 2021 | September 2024 | Allow | 35 | 1 | 0 | No | No |
| 17599081 | FUSION PROTEIN COMPRISING GROWTH DIFFERENTIATION FACTOR 11 AND HEAT SHOCK PROTEIN 10 WITH ENHANCED SKIN CELL PROLIFERATION EFFECT AND COSMETIC COMPOSITION FOR ANTI-WRINKLE COMPRISING THE SAME AS EFFECTIVE COMPONENT | September 2021 | September 2024 | Allow | 36 | 0 | 0 | No | No |
| 17598647 | PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY HERPESVIRIDAE | September 2021 | May 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17598455 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | September 2021 | April 2022 | Allow | 7 | 0 | 0 | No | No |
| 17442818 | POLYMER DRUG | September 2021 | August 2024 | Allow | 34 | 1 | 0 | No | No |
| 17593730 | TOPICAL COMPOSITION FOR TREATING BAD BODY ODORS, IN PARTICULAR HALITOSIS | September 2021 | April 2024 | Allow | 31 | 2 | 0 | No | No |
| 17481509 | ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING AN ACTIVE AGENT | September 2021 | July 2023 | Allow | 22 | 1 | 0 | No | No |
| 17481377 | Oral Care Article Comprising a Hydrophobic Delivery Carrier and Solid Hydrophilic Particle Comprising a Bleaching Agent | September 2021 | July 2023 | Allow | 22 | 1 | 0 | No | No |
| 17481524 | ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING A BLEACHING AGENT | September 2021 | July 2023 | Allow | 22 | 1 | 0 | No | No |
| 17481498 | Oral Care Article Comprising A Hydrophobic Delivery Carrier And Solid Hydrophilic Particles Comprising A Bleaching Agent | September 2021 | November 2023 | Allow | 26 | 2 | 0 | No | No |
| 17481397 | ORAL CARE ARTICLE COMPRISING A HYDROPHOBIC DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES COMPRISING AN ACTIVE AGENT | September 2021 | July 2023 | Allow | 22 | 1 | 0 | No | No |
| 17440167 | DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | September 2021 | December 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17468571 | ORAL COMPOSITIONS | September 2021 | March 2023 | Allow | 18 | 1 | 0 | No | No |
| 17468549 | ORAL COMPOSITIONS | September 2021 | March 2023 | Allow | 18 | 1 | 0 | No | No |
| 17468518 | ORAL COMPOSITIONS | September 2021 | January 2023 | Allow | 17 | 1 | 0 | No | No |
| 17436557 | PROCESS FOR THE PREPARATION AND USE OF HAIR TREATMENT COMPOSITIONS CONTAINING ORGANIC C1-C6 ALKOXY SILANES | September 2021 | January 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17435501 | Biodegradable Two-Layered Matrix for Preventing Post-Surgical Adhesions | September 2021 | April 2024 | Allow | 32 | 0 | 0 | No | No |
| 17464122 | NASAL HYGIENE METHOD AND COMPOSITION | September 2021 | October 2023 | Abandon | 25 | 2 | 0 | No | No |
| 17431529 | AN ORAL REMINERALIZATION ACCELERATING COMPOSITION | August 2021 | October 2024 | Abandon | 38 | 3 | 0 | No | No |
| 17388562 | Novel Processes and Methods | July 2021 | February 2023 | Allow | 19 | 0 | 0 | No | No |
| 17383540 | Oral Care Composition for Long-Lasting Peroxide Delivery | July 2021 | April 2024 | Abandon | 33 | 4 | 0 | No | No |
| 17372604 | ORGANIC TOOTHPASTE | July 2021 | December 2021 | Allow | 5 | 1 | 0 | No | No |
| 17363055 | MINERALIZATION AGENT AND MOUTH WASH COMPRISING THE SAME | June 2021 | May 2023 | Allow | 22 | 0 | 0 | No | No |
| 17360968 | HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONS | June 2021 | April 2024 | Allow | 33 | 2 | 0 | No | No |
| 17304901 | ADHESIVE PATCH TO ORAL CAVITY HAVING IMPROVED STABILITY AND USABILITY | June 2021 | September 2022 | Allow | 14 | 0 | 0 | No | No |
| 17356000 | Zinc Phosphate Containing Compositions | June 2021 | August 2023 | Abandon | 26 | 2 | 0 | No | No |
| 17415359 | COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI | June 2021 | January 2024 | Abandon | 31 | 1 | 1 | Yes | No |
| 17414270 | ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND NONIONIC TRIBLOCK COPOLYMERS | June 2021 | May 2023 | Allow | 23 | 0 | 0 | No | No |
| 17312985 | FIBER FOR ARTIFICIAL HAIR AND HEAD ACCESSORY PRODUCT | June 2021 | October 2023 | Allow | 29 | 1 | 0 | No | No |
| 17312974 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR CHRONOTROPIC ADMINISTRATION OF DIPEPTIDYL PEPTIDASE IV INHIBITORS | June 2021 | February 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17344572 | EFFECTIVE TEETH WHITENING COMPOSITION UTILIZING BROMELAIN ENZYMES | June 2021 | May 2024 | Abandon | 36 | 2 | 1 | No | Yes |
| 17298777 | A SULFONATED POLYSTYRENE DERIVATIVE FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF CAT FLU | June 2021 | August 2023 | Allow | 26 | 0 | 0 | No | No |
| 17303059 | Oral Care Composition for Long-Lasting Peroxide Delivery | May 2021 | April 2024 | Abandon | 35 | 4 | 0 | No | No |
| 17292386 | TRIS-SUBSTITUTED BIGUANIDE COMPOUNDS AND THEIR USES | May 2021 | March 2024 | Allow | 34 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WEBB, WALTER E.
With a 14.9% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 19.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WEBB, WALTER E works in Art Unit 1612 and has examined 1,029 patent applications in our dataset. With an allowance rate of 52.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 30 months.
Examiner WEBB, WALTER E's allowance rate of 52.1% places them in the 8% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WEBB, WALTER E receive 2.32 office actions before reaching final disposition. This places the examiner in the 79% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by WEBB, WALTER E is 30 months. This places the examiner in the 39% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +11.0% benefit to allowance rate for applications examined by WEBB, WALTER E. This interview benefit is in the 49% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 17.2% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.7% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 30.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 30% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 44.0% of appeals filed. This is in the 7% percentile among all examiners. Of these withdrawals, 44.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 66.3% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 1.1% of allowed cases (in the 69% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.